Hodgkin Lymphoma Treatment Market 2017-2022: Latest Market Dynamics Influencing the Industry – Orbis Research
Latest Report Available at Orbis research Hodgkin Lymphoma Treatment Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
(EMAILWIRE.COM, November 11, 2017 ) Request sample copy of this report @ http://www.orbisresearch.com/contacts/request-sample/220506 .
The global Hodgkin’s lymphoma treatment market is expected to grow at a CAGR of XX% during the forecast period 2016-2021. The market was valued at USD XX million in 2015 and is forecasted to reach USD XX million by 2021.
The National Cancer Institute reports an estimated 8500 new cases and 1120 deaths in 2016, due to Hodgkin’s lymphoma, in the U.S. The Hodgkin’s lymphoma market is expected to witness a lucrative growth attributed mainly to the rising healthcare expenditure and label extensions into earlier lines of treatment for Seattle Genetics’ Adcetris — which currently accounts for 77.6% of the total market and is predicted to make up 82.4% of sales by the end of the forecast period — and the launch of new therapies for relapse or refractory (R/R) Hodgkin’s lymphoma-like Bristol-Myers Squibb’s Opdivo and Merck’s Keytruda.
Global Hodgkin’s Lymphoma Treatment - Market Dynamics
The report details several factors driving and restraining the market, some of which are discussed below.
Drivers
Increasing awareness about Hodgkin’s lymphoma
Rising incidence of Hodgkin’s lymphoma
High unmet need in older patients and patients with relapsed or refractory (R/R) HL
Restraints
Adverse long-term side effects
High cost of treatment
Market Segmentation
The global Hodgkin’s lymphoma treatment market has been segmented by type of treatment into radiotherapy, chemotherapy (Doxorubicin, Bleomycin, Vinblastine, Dacarbazine, Chlorambucil, Procarbazine Prednisolone, Mustine, Vincristine, Etoposide, Cyclophosphamide, Gemcitabine, Cisplatin, Cytarabine), steroids and high-dose chemotherapy. The market has been geographically segmented into North America, Europe, Asia-Pacific, and Rest of the World.
Purchase a copy of Hodgkin Lymphoma Treatment Market visit @ http://www.orbisresearch.com/contact/purchase/220506 For more information contact sales@orbisresearch.com .
Some of the key players in the market are:
Bristol-Myers Squibb Co.
F. Hoffmann-La Roche Ltd.
Merck & Co. Inc.
Pfizer Inc.
4SC AG
Actinium Pharmaceuticals Inc.
Aeterna Zentaris Inc.
Affimed Therapeutics AG
Hospira Inc.
Incyte Corp.
Novartis AG
Others
What the Report Offers
Market definition, along with identification of key drivers and restraints for the market.
Market analysis with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the industry on both global and regional scale.
A comprehensive list of key market players, along with the analysis of their current strategic interests and key financial information.
An ideal source material for industry consultants, manufacturers and other interested and allied parties to gain critical insight into the factors driving and restraining the market, in addition to opportunities, offered.
Browse Complete Report @ http://www.orbisresearch.com/reports/index/global-hodgkin-lymphoma-treatment-market-growth-trends-and-forecasts-2017-2022 .
Some points From TOC:
INTRODUCTION
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
1.7 Report Description
RESEARCH METHODOLOGY
2.1 Introduction
2.2 Analysis Methodology
2.3 Study Timeline
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering & Econometric Model
2.4.4 Expert Validation
EXECUTIVE SUMMARY
KEY INFERENCES
MARKET OVERVIEW AND INDUSTRY TRENDS
5.1 Current Market Scenario
5.2 Market Overview
5.3 Porters Five Force Analysis
5.3.1 Bargaining Power Of Suppliers
5.3.2 Bargaining Power Of Buyers
5.3.3 Degree Of Competition
5.3.4 Threat Of Substitution
5.3.5 Threat Of New Entrants
DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 Market Drivers
6.1.1 Increase Awareness About Hodgkins Lymphoma
6.1.2 Rising Incidence of Hodgkins Lymphoma
6.1.3 High Unmet Need in Older Patients and Patients with Relapsed or Refractory (R/R) HL
6.2 Market Restraints
6.2.1 Adverse Long-Term Side Effects
6.2.2 High Cost of Treatment
6.3 Market Opportunities
6.4 Key Challenges
Global Hodgkins Lymphoma Treatment Market - Segmentation
7.1 BY TYPE OF TREATMENT
7.1.1 Radiotherapy
7.1.2 Chemotherapy
7.1.2.1 Doxorubicin
7.1.2.2 Bleomycin
7.1.2.3 Vinblastine
7.1.2.4 Dacarbazine
7.1.2.5 Chlorambucil
7.1.2.6 Procarbazine
7.1.2.7 Prednisolone
7.1.2.8 Mustine
7.1.2.9 Vincristine
7.1.2.10 Etoposide
7.1.2.11 Cyclophosphamide
7.1.2.12 Gemcitabine
7.1.2.13 Cisplatin
7.1.2.14 Cytarabine
7.1.3 Steroids
7.1.4 High-Dose Chemotherapy
For any enquires before buying, connect with us @ enquiry@orbisresearch.com
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115
The global Hodgkin’s lymphoma treatment market is expected to grow at a CAGR of XX% during the forecast period 2016-2021. The market was valued at USD XX million in 2015 and is forecasted to reach USD XX million by 2021.
The National Cancer Institute reports an estimated 8500 new cases and 1120 deaths in 2016, due to Hodgkin’s lymphoma, in the U.S. The Hodgkin’s lymphoma market is expected to witness a lucrative growth attributed mainly to the rising healthcare expenditure and label extensions into earlier lines of treatment for Seattle Genetics’ Adcetris — which currently accounts for 77.6% of the total market and is predicted to make up 82.4% of sales by the end of the forecast period — and the launch of new therapies for relapse or refractory (R/R) Hodgkin’s lymphoma-like Bristol-Myers Squibb’s Opdivo and Merck’s Keytruda.
Global Hodgkin’s Lymphoma Treatment - Market Dynamics
The report details several factors driving and restraining the market, some of which are discussed below.
Drivers
Increasing awareness about Hodgkin’s lymphoma
Rising incidence of Hodgkin’s lymphoma
High unmet need in older patients and patients with relapsed or refractory (R/R) HL
Restraints
Adverse long-term side effects
High cost of treatment
Market Segmentation
The global Hodgkin’s lymphoma treatment market has been segmented by type of treatment into radiotherapy, chemotherapy (Doxorubicin, Bleomycin, Vinblastine, Dacarbazine, Chlorambucil, Procarbazine Prednisolone, Mustine, Vincristine, Etoposide, Cyclophosphamide, Gemcitabine, Cisplatin, Cytarabine), steroids and high-dose chemotherapy. The market has been geographically segmented into North America, Europe, Asia-Pacific, and Rest of the World.
Purchase a copy of Hodgkin Lymphoma Treatment Market visit @ http://www.orbisresearch.com/contact/purchase/220506 For more information contact sales@orbisresearch.com .
Some of the key players in the market are:
Bristol-Myers Squibb Co.
F. Hoffmann-La Roche Ltd.
Merck & Co. Inc.
Pfizer Inc.
4SC AG
Actinium Pharmaceuticals Inc.
Aeterna Zentaris Inc.
Affimed Therapeutics AG
Hospira Inc.
Incyte Corp.
Novartis AG
Others
What the Report Offers
Market definition, along with identification of key drivers and restraints for the market.
Market analysis with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the industry on both global and regional scale.
A comprehensive list of key market players, along with the analysis of their current strategic interests and key financial information.
An ideal source material for industry consultants, manufacturers and other interested and allied parties to gain critical insight into the factors driving and restraining the market, in addition to opportunities, offered.
Browse Complete Report @ http://www.orbisresearch.com/reports/index/global-hodgkin-lymphoma-treatment-market-growth-trends-and-forecasts-2017-2022 .
Some points From TOC:
INTRODUCTION
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
1.7 Report Description
RESEARCH METHODOLOGY
2.1 Introduction
2.2 Analysis Methodology
2.3 Study Timeline
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering & Econometric Model
2.4.4 Expert Validation
EXECUTIVE SUMMARY
KEY INFERENCES
MARKET OVERVIEW AND INDUSTRY TRENDS
5.1 Current Market Scenario
5.2 Market Overview
5.3 Porters Five Force Analysis
5.3.1 Bargaining Power Of Suppliers
5.3.2 Bargaining Power Of Buyers
5.3.3 Degree Of Competition
5.3.4 Threat Of Substitution
5.3.5 Threat Of New Entrants
DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 Market Drivers
6.1.1 Increase Awareness About Hodgkins Lymphoma
6.1.2 Rising Incidence of Hodgkins Lymphoma
6.1.3 High Unmet Need in Older Patients and Patients with Relapsed or Refractory (R/R) HL
6.2 Market Restraints
6.2.1 Adverse Long-Term Side Effects
6.2.2 High Cost of Treatment
6.3 Market Opportunities
6.4 Key Challenges
Global Hodgkins Lymphoma Treatment Market - Segmentation
7.1 BY TYPE OF TREATMENT
7.1.1 Radiotherapy
7.1.2 Chemotherapy
7.1.2.1 Doxorubicin
7.1.2.2 Bleomycin
7.1.2.3 Vinblastine
7.1.2.4 Dacarbazine
7.1.2.5 Chlorambucil
7.1.2.6 Procarbazine
7.1.2.7 Prednisolone
7.1.2.8 Mustine
7.1.2.9 Vincristine
7.1.2.10 Etoposide
7.1.2.11 Cyclophosphamide
7.1.2.12 Gemcitabine
7.1.2.13 Cisplatin
7.1.2.14 Cytarabine
7.1.3 Steroids
7.1.4 High-Dose Chemotherapy
For any enquires before buying, connect with us @ enquiry@orbisresearch.com
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115
Contact Information:
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results